Pharmaceutical firms opt to slash wholesaler profit margin

Korea’s pharmaceutical sector is now headed for a fresh round of restructuring, with major companies pushing employees to opt for early retirement plans amid growing worries over the lackluster earnings outlook.

Domestic drug firms are taking steps to reduce their promotional expenditures and workforces as they brace for lower earnings due to the stronger regulatory supervision including a c...